Price, one year
Price range
- Open
- ₹194.00
- High
- ₹194.91
- Low
- ₹185.02
- Previous close
- ₹194.99
- Volume
- 24.7 L
- Market cap
- ₹25,438 Cr
Key statistics
Results to 30 Jun 2026 · Consolidated- P/E (TTM)
- —
- Price to book
- 3.1
- Return on equity
- −3.8%
- EPS (TTM)
- ₹−2.37
- Book value / share
- ₹61.31
- Debt to equity
- 0.67
- Revenue (TTM)
- ₹9,205 Cr
- Net profit (TTM)
- ₹−314 Cr
- Sales growth, YoY
- +17.4%
- Profit growth, YoY
- —
- Operating margin
- 11.0%
- Net margin
- −3.4%
- Sales CAGR, 3 years
- +7.8%
- Profit CAGR, 3 years
- —
- Promoter holding
- 34.80%
- Promoter shares pledged
- 0.00%
Shareholding pattern
% of shares| Holder | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|
| Promoters | 34.86 | 34.80 | 34.80 |
| Foreign institutions | 30.18 | 12.52 | 13.65 |
| Domestic institutions | 15.61 | 14.57 | 14.44 |
| Mutual funds | 14.12 | 13.18 | 12.71 |
| Retail and others | 13.74 | 14.54 | 13.27 |
Results and announcements
Latest results (quarter to 30 Jun 2026) filed 29 Jul 2026. results: 27 Oct 2026.
- 16 Oct 2026 · Investor meetAnalysts/Institutional Investor Meet/Con. Call UpdatesPiramal Pharma Limited has informed the Exchange about Schedule of meet
Peers in Healthcare
All Healthcare stocks| Company | Price | Change |
|---|---|---|
| Sun Pharmaceutical IndustriesSUNPHARMA | ₹1,748.00 | −0.57% |
| Divi's LaboratoriesDIVISLAB | ₹8,950.00 | −2.31% |
| Torrent PharmaceuticalsTORNTPHARM | ₹4,524.40 | −1.97% |
| Zydus LifesciencesZYDUSLIFE | ₹1,129.40 | −0.49% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | ₹7,730.00 | +1.65% |
| CiplaCIPLA | ₹1,338.00 | +0.53% |
| Laurus LabsLAURUSLABS | ₹1,970.00 | −1.62% |
| Dr. Reddy's LaboratoriesDRREDDY | ₹1,229.50 | −0.77% |
| Mankind PharmaMANKIND | ₹2,212.60 | −2.77% |
| Aurobindo PharmaAUROPHARMA | ₹1,571.70 | −2.43% |
Frequently asked questions
What is the share price of Piramal Pharma today?
Piramal Pharma (NSE: PPLPHARMA) was at ₹191.07 on 23 Oct 2026, a change of −2.01% from the previous close.
What are the 52-week high and low of Piramal Pharma?
Over the last 52 weeks Piramal Pharma traded between ₹132.30 and ₹231.93 (daily highs and lows on NSE on 23 Oct 2026).
What is the market capitalisation of Piramal Pharma?
About ₹25,438 Cr at the latest price, with a price-to-book of 3.1, a return on equity of −3.8%. Ratios use the company's latest reported results.
Who owns Piramal Pharma shares?
According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 34.80%, foreign institutions 13.65%, domestic institutions 14.44%.
Which sector and indices does Piramal Pharma belong to?
NSE classifies Piramal Pharma under Healthcare; it is a member of Nifty 500.
Follow Piramal Pharma with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.
Start free trial